Literature DB >> 15981095

Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells.

A Karolina Palucka1, John Connolly, Hideki Ueno, John Kohl, Sophie Paczesny, Madhav Dhodapkar, Joseph Fay, Jacques Banchereau.   

Abstract

We observed the induction of spontaneous, i.e., without adding exogenous antigen, in vitro proliferation of PBMCs from patients with stage IV melanoma who underwent repeated vaccinations with antigen-loaded dendritic cells (DCs) derived from CD34(+) hematopoietic progenitors (CD34-DCs). Proliferating cells are CD4(+)T cells. Their proliferation is dependent on (1) CD11c(+) myeloid DCs, since their depletion from PBMCs abolishes it; and (2) IL-2, as it can be blocked by neutralizing anti-IL-2 antibodies. Spontaneous proliferation is associated to the secretion of type 2 cytokines. To analyze the frequency of spontaneous proliferation induction in the cohort of 18 vaccinated patients, an index of spontaneous proliferation was defined as a ratio of PBMCs proliferation from post- vs pre-DC vaccination blood samples. Ten out of sixteen analyzed patients showed an index > 2. The index of spontaneous proliferation correlates with antigen-specific PBMC proliferation to the vaccine antigen KLH. Furthermore, both spontaneous- and antigen-specific proliferation in PBMC cultures are dependent on blood myeloid DCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981095     DOI: 10.1007/s10875-005-4089-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 3.  Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses.

Authors:  Benedita Rocha; Corinne Tanchot
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

4.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Authors:  J Banchereau; A K Palucka; M Dhodapkar; S Burkeholder; N Taquet; A Rolland; S Taquet; S Coquery; K M Wittkowski; N Bhardwaj; L Pineiro; R Steinman; J Fay
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma.

Authors:  A Karolina Palucka; Madhav V Dhodapkar; Sophie Paczesny; Susan Burkeholder; Knut M Wittkowski; Ralph M Steinman; Joseph Fay; Jacques Banchereau
Journal:  J Immunother       Date:  2003 Sep-Oct       Impact factor: 4.456

6.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

7.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.

Authors:  Sophie Paczesny; Jacques Banchereau; Knut M Wittkowski; Giovanna Saracino; Joseph Fay; A Karolina Palucka
Journal:  J Exp Med       Date:  2004-06-01       Impact factor: 14.307

9.  Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

Authors:  C M Celluzzi; J I Mayordomo; W J Storkus; M T Lotze; L D Falo
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Dendritic cells: are they clinically relevant?

Authors:  Karolina Palucka; Hideki Ueno; Lee Roberts; Joseph Fay; Jacques Banchereau
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

2.  Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Authors:  Mayu O Frank; Julia Kaufman; Suyan Tian; Mayte Suárez-Fariñas; Salina Parveen; Nathalie E Blachère; Michael J Morris; Susan Slovin; Howard I Scher; Matthew L Albert; Robert B Darnell
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

3.  Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Authors:  Duane A Mitchell; Kristen A Batich; Michael D Gunn; Min-Nung Huang; Luis Sanchez-Perez; Smita K Nair; Kendra L Congdon; Elizabeth A Reap; Gary E Archer; Annick Desjardins; Allan H Friedman; Henry S Friedman; James E Herndon; April Coan; Roger E McLendon; David A Reardon; James J Vredenburgh; Darell D Bigner; John H Sampson
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.